Regulating next generation agri-food biotechnologies : Lessons from European, Norlth American and Asian experiences

Table of contents
Acknowledgment;
Introduction;
Chapter 1: Regulating Next Generation Biotechnologies: Tentative Regulation for Emerging Technologies by David Laycock and Michael Howlett;
Part 1: First and Second Generation Agri-Food Genetic Technologies and Regulatory Regimes: Issues and Overviews;
Chapter 2: Generating Regulatory Futures: From Agbiotech Blockages to a Bioeconomy? by Les Levidow; Chapter 3: Learning From Experience: How Do We Use What We've Learned to Reform Regulatory Oversight of New Agricultural Biotechnologies? by Alan McHughen;
Part 2: Regulatory Regime Development Theory & Practice;
Chapter 4: Regulatory Life Cycles and Comparative Biotechnology Regulation: Analyzing Regulatory Regimes in Space and Time by Michael Howlett and Andrea Migone;
Chapter 5: Pragmatism Revisited: An overview of the development of regulatory regimes of GMOs in EU by Anders Johansson;
Part 3: GMO Regulatory Regimes in Practice: Europe, Asia, and North America;
Chapter 6: Contested Frames: Comparing EU versus US GMO Policy by Sarah Lieberman and Anthony R. Zito; Chapter 7: The Global battle over the Governance of Agricultural Biotechnology: the roles of Japan, Korea, and China by Yves Tiberghien;
Chapter 8: The EU's Governance of Plant Biotechnology Risk Regulation: Still Contested, Still Distinct by Paulette Kurzer and Grace Skogstad;
Part 4: Lessons from Other High Technology Sectors;
Chapter 9: Regulating Nanotechnology in China: Governance, Risk Management, and Regulatory Effectiveness by Darryl S.L. Jarvis and Noah Richmond;
Chapter 10: Lessons from Bio-Medical Technology Regulation: North American and European Comparisons by Isabelle Engeli, Christine Rothmayr Allison, and Frederic Varone;
Part 5: Agricultural Biotechnologies and the Public: Deliberation, Opinion, Ethics and Participatio;
Chapter 11: Network Deliberations, Advocacy Groups and the Legitimacy of the EU by Eric Montpetit;
Chapter 12: Getting to Maybe: Assessments of Benefits and Risks in Canadian Public Opinion On Biotechnological Innovation by Steven Weldon, David Laycock, Andrea Nusser, and Colin Whelan;
Chapter 13: Deriving Policy and Governance from Deliberative Events and Mini-Publics by Michael M. Burgess; Chapter 14: Second Generation Governance for Second Generation GM by Christoph Rehmann-Sutter